AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Vildaford-Met Tablet

Prescription Icon
Prescription Required

Marketer

Medford Pharmaceuticals

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildaford-Met Tablet

Metformin-Vilda combination tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action therapy mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may also lessen the probability of cardiovascular events. This medication may be administered independently or in conjunction with other antidiabetic agents. Optimal therapeutic response requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Maintaining controlled blood sugar levels helps prevent future complications. Continued commitment to your prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts glycemic control. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its symptoms and management. This medication is not universally suitable. Prior to initiation, inform your doctor of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Drug interactions are possible; disclose all medications to your physician to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted throughout treatment.

Primary Ingredients of Vildaford-Met Tablet

The provided text is "undefined," therefore no rewriting is possible.

Uses of Vildaford-Met Tablet

Managing Type 2 diabetes

Major Benefits of Vildaford-Met Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Vildaford-Met Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Vildaford-Met Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildaford-Met Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Vildaford-Met Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Vildaford-Met Tablet works:

Metformin and vildagliptin are combined in Vildaford-Met tablets to treat diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Vildaford-Met tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildaford-Met tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Vildaford-Met tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildaford-Met Tablets, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver conditions should not take Vildaford-Met tablets due to the significant risk of adverse effects. Medical advice is recommended.

What if you forget to take Vildaford-Met Tablet :

Should you forget a Vildaford-Met Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildaford-Met Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildaford-Met Tablet

Vildaford-Met Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using the medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildaford-Met Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Vildaford-Met Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildagliptin-Metformin tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Vildaford-Met Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildaford-Met immediately and seek medical attention.
Prolonged Vildaford-Met Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Vildaford-Met Tablets are safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulfonylurea). Report any persistent problems to your doctor.
Vildaford-Met Tablet
80
MRP 93
13% off